Search Results

You are looking at 41 - 50 of 517 items for :

  • Refine by Access: All x
Clear All
Full access

Tarek Haykal, Babikir Kheiri, Varun Samji, Yazan Zayed, Ragheed Al-Dulaimi, Inderdeep Gakhal, Areeg Bala, Jason Sotzen, Ahmed Abdalla, and Ghassan Bachuwa

Foundation, Vienna, Austria). Results: We included 8 RCTs, with a total of 4,106 patients. The mean age was 62, with 66.44% males. Any grade AEs were reported in 72% of patients with the following frequencies: fatigue, 44%; diarrhea, 38%; nausea, 31%; hand

Full access

Oxana Palesh, Arianna Aldridge-Gerry, Ayhan Ulusakarya, Elisabet Ortiz-Tudela, Lucile Capuron, and Pasquale F. Innominato

. For clinical diagnosis, these difficulties are typically associated with daytime impairment, such as fatigue or excessive sleepiness at least 3 times a week for 30 minutes or more for at least 1 month. Nearly 80% of women undergoing chemotherapy for

Full access

Yuan-Yuan Lei, Suzanne C. Ho, Ashley Cheng, Carol Kwok, Chi-Kiu Iris Lee, Ka Li Cheung, Roselle Lee, Herbert H.F. Loong, Yi-Qian He, and Winnie Yeo

-specific HRQoL issues relevant to a broad spectrum of patients with cancer. 30 The QLQ-C30 included a global health and QoL domain, 5 functional domains (physical, role, emotional, cognitive, and social), 3 symptom domains (fatigue, nausea and vomiting, and pain

Full access

Rodger J. Winn

-controlled trial . J Clin Oncol 2001 ; 19 : 2865 - 2874 . 2 Berndt E Kallich J McDermott A . Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy . Pharmacoeconomics 2005 ; 23

Full access

Karolina Kata, Juan C. Rodriguez-Quintero, Octavio D. Arevalo, Jackie J. Zhang, Meenakshi Bidwai Bhattacharjee, Cornelius Ware, Antonio Dono, Roy Riascos-Castaneda, Nitin Tandon, Angel Blanco, Yoshua Esquenazi, Leomar Y. Ballester, Mark Amsbaugh, Arthur L. Day, and Jay-Jiguang Zhu

reported significant improvement in nutrition and ambulation. Due to new bony metastases, nivolumab and ipilimumab were added in January 2020 while maintaining encorafenib and binimetinib. While on this regimen for 4 months, with fatigue as the only AE

Full access

Kevin O’Brien, Rahul Dave, Skand Shekhar, Fady Hannah-Shmouni, Leora E. Comis, Beth I. Solomon, Marcus Chen, William A. Gahl, Edmond FitzGibbon, Bernadette R. Gochuico, and Juvianee I. Estrada-Veras

, in combination with ostalgia, fatigue, and asthenia, can create balance, gait, and gross and fine motor coordination difficulties. 22 Deficits can range from mild issues resulting in subtle changes that can be readily addressed with occupational

Full access

Nisar Ahmad, Denise M. Adams, Jiang Wang, Rajan Prakash, and Nagla Abdel Karim

past medical history presented with right upper quadrant abdominal pain, fatigue, poor appetite, and an approximately 20-lb weight loss over 2 to 3 months. She denied alcohol or illicit drug use. She had smoked half a pack of cigarettes per day for many

Full access

Amy A. Kirkham, Riggs J. Klika, Tara Ballard, Paul Downey, and Kristin L. Campbell

A review of randomized controlled trials by a panel of clinical and research experts confirmed that during and after cancer treatment, exercise is safe and beneficial for reducing many common sequelae of cancer treatment, such as fatigue

Full access

William G. Wierda, John C. Byrd, Jeremy S. Abramson, Seema Bhat, Greg Bociek, Danielle Brander, Jennifer Brown, Asher Chanan-Khan, Steve E. Coutre, Randall S. Davis, Christopher D. Fletcher, Brian Hill, Brad S. Kahl, Manali Kamdar, Lawrence D. Kaplan, Nadia Khan, Thomas J. Kipps, Jeffrey Lancet, Shuo Ma, Sami Malek, Claudio Mosse, Mazyar Shadman, Tanya Siddiqi, Deborah Stephens, Nina Wagner, Andrew D. Zelenetz, Mary A. Dwyer, and Hema Sundar

, HCL is characterized by symptoms of fatigue and weakness, and most patients will present with splenomegaly (symptomatic or asymptomatic) and/or hepatomegaly, pancytopenia, and uncommonly peripheral lymphadenopathy. 2 Additionally, patients may also

Full access

Namrata Vijayvergia, Prashant C. Shah, and Crystal S. Denlinger

study of JBR.10 participants, global QOL declined in both the observation and chemotherapy arms, with both groups experiencing high symptom burden related to fatigue and postsurgical pain. A higher proportion of patients in the observation arm reported